BP000281-CHM-347: Recombinant Human MIP-1 α (CCL3), His Tag
Source: E. coli-derived.
Purity: > 95%, by RP-HPLC and SDS-PAGE.BP000282-CHM-003: Recombinant Rat MIP-1β (CCL4) Protein
Source: E. coli-derived.
Determined by its ability to chemoattract human monocytes using a concentration range of 0.01-1.0 ug/ml.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000282-CHM-276: Recombinant Human MIP-1β (CCL4) Protein
Source: E. coli-derived.
The activity is calculated by the ability to chemoattract Human blood monocytes using a concentration of 5-20 ug/ml corresponding to a Specific Activity of 50,000-200,000 IU/mg.
Purity > 99%, by SDS-PAGE and RP-HPLC.BP000282-CHM-321: Recombinant Mouse MIP-1β (CCL4) Protein
Source: E. coli-derived.
Mouse MIP-1 beta activity is calculated by the ability to chemoattract Human blood monocytes at 20-100 ug/ml corresponding to a Specific Activity of 10,000-50,000 IU/mg.
Purity > 98%, by SDS--PAGE and RP-HPLC.BP000302-CHM-234: Human C-X-C Motif Chemokine Ligand 4 (CXCL4) Protein
Source: Human Platelets-derived.
Purity: > 95% by RP-HPLC and SDS-PAGE.BP000302-CHM-243: Recombinant Human C-X-C Motif Chemokine Ligand 4 (CXCL4) Variant 1 Protein
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000302-CHM-245: Recombinant Mouse C-X-C Motif Chemokine Ligand 4 (CXCL4) Protein
Source: E. coli-derived.
Purity: > 97% by RP-HPLC and SDS-PAGE.BP000302-CHM-350: Recombinant Human C-X-C Motif Chemokine Ligand 4 (CXCL4) Protein
Source: E. coli-derived.
The ED50 of CXCL4 as determined by its ability to inhibit human FGF basic dependent proliferation of NR6R3T3 mouse fibroblasts was found to be 5-15 ?/ml.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000313-PRO-471: Recombinant Human CD31
Source: E. coli-derived.
Applications: ELISA; Inhibition Assays; WB.